Cardiomyopathy

Cardiomyopathy generally caused by treatments of chemotherapeutic medications, or group of diseases, that leads to damage of the heart muscle. This injury can interfere with the pumping action of the heart and eventually lead to heart failure. Anthracyclines, drugs that cause cardiomyopathy, are used to treat for diseases like breast cancer, leukemia, lymphoma, and sarcoma. An example of an anthracycline is called doxorubicin (Adriamycin), which at certain dosage can have cardiotoxic effects on the

Cardiomyopathy, Raynaud’s and Perfusion Adequate perfusion supplies the entire body with necessary oxygen and nutrients to sustain life. The process of oxygenation and perfusion can be affected by a multitude of factors. A few examples are, a decreased oxygen carrying capacity, hypovolemia, neuromuscular disease, central nervous system alterations and chronic diseases (Potter, Perry, Stockert, & Hall, 2013, p. 826). Two specific examples of conditions affecting perfusion are cardiomyopathy and

Cardiomyopathy and Congestive Heart Failure: An Approach to Care and Treatment Mr. P, a 76-year-old male, presents to the hospital with CHF exacerbation and symptoms include 4+ pitting edema, dyspnea, and lung auscultation reveals crackles throughout. He has had repeated hospitalization related to the same condition. During the course of his hospital stay the nurse will develop a treatment plan for discharge and provide education regarding how his care will be approached during his admission and

Dilated cardiomyopathy was first time registered in Heart Muscle Disease Registry in Trieste in 1978 and about 747 patients with DCM enlisted up to 2007 by Aleksova (2009). The systolic ventricular function is impaired is registered in British heart journal (1980). Merlo (2007) described that DCM is a group of different diseases. dilated cardiomyopathy is described as a progressive ventricular wall thinning and dilatation. 2.2 Proteins involved in Contractile machinery out of India. 2.2.1

Hypertrophic Cardiomyopathy, specifically focusing on the pediatric population, and even more narrowing on athletes. This is a growing area of concern in the medical field due to the undetected Hypertrophic Cardiomyopathy in athletes until a Sudden Cardiac Death (SCD). Shockingly many athletes are instantly dying on the soccer field and basketball courts not even aware there is a cardiac issue until it is too late. The following paragraphs will explore what is Hypertrophic Cardiomyopathy, who is affected

Cardiomyopathy is when there is an enlargement of the heart. This can cause various problems for the person who carries this heart disease. Cardiomyopathy refers to the heart muscle when it is enlarged, thick muscle walls or rigid. In rare cases the heart muscle tissue can be replaced by scar tissue which may lead to fatal consequences. If left untreated the heart condition worsens meaning that its heart pulses become weaker and the heart is unable to maintain its normal electrical rhythmic beating

the body, the heart is susceptible to disease. Cardiomyopathy also known as “disease of the heart muscle” affects 1 in 500 adults and is the leading source of heart failure and the most common reason for needing a heart transplant (Texas Heart Institute, 2016). One of the rarest forms of cardiomyopathy is termed restrictive cardiomyopathy, accounting for less than 5 % of all cardiac disease (TheHeart.org, 2017). By definition, restrictive cardiomyopathy is a disease of the myocardium characterized

treatments. The individual in this case has cardiomyopathy and, because of that his heart muscle is in a weakened condition therefore, strengthening the heart is one of the primary goals of treatment. Due to the seriousness of this heart condition it is imperative that this individual receives all the appropriate medications needed for a situation of this nature, which should include ACE inhibitors and beta blockers, due to the fact that the cardiomyopathy has led to congestive heart failure. These

Dilated cardiomyopathy (DCM) is a disorder caused by abnormalities in functional regions of the heart muscle. [Maron et al., 2006] It is one of two major types of cardiomyopathies, the other being hypertrophic cardiomyopathy (HCM). In DCM the ventricles are dilated with dysfunctional systolic pressure, affecting 1 in 2500 individuals. [Codd et al., 1989, Pahl, 2010] Familial DCM is diagnosed when two or more family members die or there is sudden death of a child due to DCM. [Mestroni et al., 1999]

Cardiomyopathy, Adult Cardiomyopathy is a long-term (chronic) disease of the heart muscle. The disease makes your heart muscle thick, weak, or stiff. As a result your heart has to work harder to pump blood. Over time cardiomyopathy can lead to heart failure. There are several types of cardiomyopathy: Dilated cardiomyopathy. This type causes the ventricles become weak and stretched out. Hypertrophic cardiomyopathy. This type causes the heart muscle to thicken. Restrictive cardiomyopathy